Cancer and Hernia to Support the Demand for Handheld Ligation Devices Worldwide

Growth in this market is mainly driven by the increasing prevalence of diseases requiring surgical treatment, especially minimally invasive surgery (MIS).

However, the high cost of ligation devices is a major restraint for this market, particularly in emerging countries.The ligation devices market is projected to reach USD 1,189 million by 2024 from USD 876 million in 2019, at a CAGR of 6.3%.Accessories are expected to fuel the growth of the ligation devices market over the forecast period.By product, the ligation devices market is segmented into handheld instruments and accessories.

The accessories segment accounted for a share of 68.2% in 2018 and is anticipated to grow at a CAGR of 6.9% during the forecast period.

This growth can be attributed to the increasing number of surgical procedures, especially in emerging markets.Increasing use of ligation devices in gastrointestinal & abdominal surgeries to drive market growth during the forecast periodBased on applications, the ligation devices market is segmented into gastrointestinal & abdominal surgeries, gynecological surgeries, cardiovascular surgeries, urological surgeries, and other applications such as wound, ENT, and cosmetic applications.

The cardiovascular surgeries segment is anticipated to drive growth in the market at a CAGR of 6.9% over the forecast period.

This growth can be attributed to the increase in the incidence of cardiovascular diseases.

Global Varicose Veins Treatment Market Overview By Type (Surgical Ligation, Stripping, Laser Ablations, Endovenous Ablation and Sclerotherapy), Regional Outlook, Industry Trend and Insights, Forecast To 2023

The global Varicose Veins Treatment Market was estimated at USD 415.9 million in 2017 and is expected to grow at cagr of 7.4% over the forecast period.

Moreover, varicose veins surgical procedures are bound to undergo tremendous changes in the coming years, with surgery being largely replaced by noninvasive procedures.

This holds true on the basis of various benefits this treatment offers, such as less bruising and scarring; no need for prolonged hospital stay, no need for sedation; positive reimbursement policies as well as simple follow-up treatments.

The product-wise segments in the market are ablation devices, venous closure products and surgical products.

The market, by end user, has been segmented into hospitals, specialized clinics, ambulatory surgical centers and others.

The global Tubal Ligation Market research report, published by Value Market Research, is designed to offer various market framework such as market size, portion, trends, growth path, value and factors that impact the current market dynamics over the forecast period 2020-2027.

Most importantly, this report also provides the latest significant strategies adopted by major players along with their market share.The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide.

The major players in the tubal ligation market include Medtronic plc, Ethicon, B. Braun Melsungen AG, Pregna International Ltd., Cardinal Health, CONMED Corporation, CooperSurgical Inc., Bayer AG, Olympus Corporation, Smith & Nephew, Becton, Dickinson and Company.

This section includes a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developmentsGet more information on "Global Tubal Ligation Market Research Report" by requesting FREE Sample Copy at https://www.valuemarketresearch.com/contact/tubal-ligation-market/download-sampleMarket DynamicsRapidly expanding population, the growing trend of nuclear families, and improving living conditions are the main drivers of the tubal ligation market.

The increasing awareness and extended access to family planning services to uninsured populations through the Medicaid family planning expansion program further accelerate the market’s growth.

However, limited access to services in rural areas, low-income families, fear or experience of side-effects, and cultural or religious opposition restrains the market growth.The report covers Porter’s Five Forces Model, Market Attractiveness Analysis and Value Chain analysis.

The newly added Tubal Ligation Market research report by Value Market Research disclose all the important information associated with the market such as value, growth factor, trends, market share, size, and challenges for the forecasted timeline 2020-2027.

Basically, this report is designed to give a proper understanding of industry structure and competition intensity attractiveness.The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide.

The major players in the tubal ligation market include Medtronic plc, Ethicon, B. Braun Melsungen AG, Pregna International Ltd., Cardinal Health, CONMED Corporation, CooperSurgical Inc., Bayer AG, Olympus Corporation, Smith& Nephew, Becton, Dickinson and Company.

This section includes a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developmentsGet more information on "Global Tubal Ligation Market Research Report" by requesting FREE Sample Copy athttps://www.valuemarketresearch.com/contact/tubal-ligation-market/download-sampleMarket DynamicsRapidly expanding population, the growing trend of nuclear families, and improving living conditions are the main drivers of the tubal ligation market.

The increasing awareness and extended access to family planning services to uninsured populations through the Medicaid family planning expansion program further accelerate the market’s growth.

However, limited access to services in rural areas, low-income families, fear or experience of side-effects, and cultural or religious opposition restrains the market growth.